Anticavity Fluoride Rinse

Description

Sodium Fluoride and Acidulated Phosphate Topical Solution is a dental care formulation designed to aid in the prevention of cavities and the restoration of enamel. This solution is presented in a fresh mint flavor, contributing to an enhanced user experience. It is formulated to strengthen teeth and effectively eliminate germs associated with bad breath, resulting in a clean mouth feel. The product is available in a 1-liter (33.8 fl oz) container.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It aids in cavity prevention by restoring enamel and strengthening teeth. Additionally, it helps eliminate bad breath germs, contributing to an overall clean feeling in the mouth.

Limitations of Use: This product is intended for use as part of a comprehensive oral hygiene regimen and should not be considered a substitute for regular dental care.

Dosage and Administration

Adults and children aged 12 years and older are instructed to use the rinse twice daily, following brushing with toothpaste. The recommended method involves vigorously swishing 10 mL (2 teaspoonfuls) of the rinse between the teeth for a duration of 1 minute, after which the solution should be expectorated. It is imperative that the rinse is not swallowed.

Patients should refrain from eating or drinking for 30 minutes following the rinsing procedure to ensure optimal efficacy. For children under 12 years of age, it is advised to consult a dentist or physician prior to use. Additionally, caregivers should instruct children in proper rinsing techniques to minimize the risk of swallowing the rinse and supervise them as necessary until they are capable of using the product independently.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if more than the recommended amount used for rinsing is accidentally swallowed, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Warnings and Precautions

Warning: This product should be used with caution.

General precautions must be observed to ensure safety. It is imperative to keep this product out of reach of children to prevent accidental ingestion. In the event that more than the recommended amount for rinsing is swallowed, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

No specific laboratory tests or monitoring parameters have been provided for this product. Therefore, healthcare professionals should remain vigilant and assess the patient's condition as necessary.

Side Effects

No specific side effects are listed in this section. Therefore, there are no adverse reactions to report based on the available data.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Anticavity Fluoride Rinse (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep the product out of reach of children. In the event that more than the recommended amount for rinsing is accidentally swallowed, medical assistance or contact with a Poison Control Center is advised immediately.

For efficacy, the product is indicated for use in adults and children aged 12 years and older, with a recommended dosage of twice daily following tooth brushing. Children under 12 years of age should be guided in proper rinsing techniques to minimize the risk of swallowing the product. Supervision is recommended for these younger patients until they demonstrate the ability to use the product without assistance. Additionally, it is advised that parents or guardians consult a dentist or doctor regarding the use of the product in children under 12 years of age.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this medication. While specific contraindications are not mentioned, caution is advised due to the lack of well-documented safety data regarding sodium fluoride use in pregnant patients. The prescribing information does not detail potential risks to the fetus, and no specific dosage modifications for pregnant individuals are provided. Additionally, there are no special precautions regarding the use of this medication during pregnancy. Healthcare professionals should weigh the potential benefits against the unknown risks when considering this treatment for women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential to monitor renal function tests regularly in these patients to ensure appropriate dosing and minimize the risk of adverse effects. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose may be required. Special consideration should be given to patients with severe renal impairment to ensure their safety and the efficacy of treatment.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to potential alterations in hepatic metabolism. It is essential to exercise caution when administering the drug to this population. Special monitoring of liver function tests is recommended to ensure patient safety and to assess the need for further dosage modifications. Regular evaluation of liver function will help in managing any risks associated with compromised liver function.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols tailored to the substance involved. Continuous assessment and supportive measures should be prioritized to ensure patient safety and mitigate potential complications associated with overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. It is important to inform patients that if more than the recommended amount used for rinsing is accidentally swallowed, they should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and addressing any potential risks associated with misuse.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at a controlled room temperature ranging from 20°C to 25°C (68°F to 77°F).

Care should be taken during colder weather conditions, as exposure to low temperatures may cause temporary cloudiness in the product. Proper storage conditions are crucial to maintain the integrity and quality of the product.

Additional Clinical Information

The product is administered orally, with a recommended frequency of twice daily following tooth brushing with toothpaste. Clinicians should advise patients to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if more than the recommended amount is accidentally swallowed.

For children under 12 years of age, it is important to instruct them on proper rinsing techniques to minimize swallowing and to supervise their use until they are capable of using the product independently. Additionally, consultation with a dentist or doctor is recommended for this age group.

Drug Information (PDF)

This file contains official product information for Anticavity Fluoride Rinse, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)